- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04745598
Impact Evaluation of Personalized Oral Hygiene Education on Periodontal Patients Stage I/II/III (HygParo)
Evaluation of personalized oral hygiene education on plaque accumulation and gingival inflammation in periodontal patients stage I/II/III.
Evaluation of personalized oral hygiene education on clinical attachment level in periodontal patients stage I/II/III.
Evaluation of personalized oral hygiene education on the psychological determinants described by the Health Action Process Approach (HAPA) and the mediating role of these psychological determinants in oral hygiene habits and clinical parameters in periodontal patients stage I/II/III.
Studieoversikt
Status
Studietype
Registrering (Forventet)
Kontakter og plasseringer
Studiesteder
-
-
-
Strasbourg, Frankrike, 67091
- Les Hôpitaux Universitaires de Strasbourg
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion criteria:
- ≥ 18 years old
- Subject having signed an informed consent
- Subjects with periodontal disease Stage I/II/III :
- ≥ 15 teeth/implants
- Bleeding index at ≥ 25%
- Plaque index ≥ 20%
- Not requiring antibiotic prophylaxis prior to periodontal treatment.
- Not having received surgical periodontal treatment in the last 12 months.
- Smokers of ≤10 cigarettes/day
Exclusion criteria:
- <15 teeth/implants
- Physical or mental disability that does not allow for the performance of oral hygiene procedures.
- Chronic progressive pathology (diabetes...) / immunodeficiencies (HIV...)/ systemic infections.
- Ongoing drug treatment leading to a significant change in the periodontal condition (anti-epileptics, calcium antagonists, immunosuppressants, hormonal treatments, etc.).
- Ongoing drug treatment that can influence the periodontal condition (anti-inflammatory drugs, antibiotics)
- Patients with severe xerostomia or with Gougerot-Sjögren's syndrome.
- Subjects undergoing treatment for cancer
- Pregnant or breastfeeding women
- Smokers of > 10 cigarettes/day
- Impossibility to give information about the subject (subject in an emergency situation, difficulties in understanding the French language, etc.).
- Subject under safeguard of justice
- Subject under guardianship or curatorship
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Control group: Dental model
Patients diagnosed with periodontal disease stage I/II/III
|
- Patients receive a demonstration of plaque control methods (modified Bass dental brushing technique and the use of the electric toothbrush) using a dental model.
|
|
Computer-assisted teaching format group
Patients diagnosed with periodontal disease stage I/II/III
|
- Patients receive a Powerpoint presentation containing:
|
|
Plaque-disclosing group
Patients diagnosed with periodontal disease stage I/II/III
|
- Patients place a few drops of a plaque-disclosing solution on the tongue and run the tongue over all the teeth and gums.
With the aid of a hand mirror, patients can observe the stained plaque residue on their teeth
|
|
Intra-oral Camera group
Patients diagnosed with periodontal disease stage I/II/III
|
- An ACTEON Soprocare® intraoral camera is used during the examination and explanation of oral hygiene strategies.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Evaluation of the plaque index
Tidsramme: 3 months
|
Plaque Index (Loë and Silness, 1963): Six surfaces per tooth (buccal, mesio-buccal, disto-buccal, lingual, mesio-lingual and disto-lingual) are examined in every permanent tooth (except for third molars). Each tooth is assessed with a score between 0 and 3.
|
3 months
|
|
Evaluation of the gingival index
Tidsramme: 3 months
|
Gingival Index (Loë 1967): Six surfaces per tooth (buccal, mesio-buccal, disto-buccal, lingual, mesio-lingual and disto-lingual) are examined in every permanent tooth (except for third molars).
|
3 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Evaluation of probing pocket depth
Tidsramme: 3 months
|
Probing pocket depth (distance from the top of the marginal gingiva to the bottom of the pocket)
|
3 months
|
|
Evaluation of the gingival attachment level
Tidsramme: 3 months
|
Gingival attachment level (distance separating the cemento-enamel junction from the bottom of the pocket)
|
3 months
|
|
Psychological determinants of the HAPA (Health Action Process Approach)
Tidsramme: 3 months
|
Change in the psychological determinants of the HAPA questionnaire adapted to oral health, using a 7-point Likert scale from "strongly disagree" (1) to "strongly agree" (7)
|
3 months
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Forventet)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 8091
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .